BioRestorative Therapies, Inc.
BRTX
$1.71
$0.021.18%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 10.73M | 13.09M | 14.68M | 16.42M | 11.07M |
Total Receivables | 188.40K | 165.00K | 27.40K | 35.00K | 19.30K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 223.20K | 233.70K | 295.90K | 317.00K | 305.20K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | 22.40K | -- | -- | -- |
Total Current Assets | 11.14M | 13.51M | 15.00M | 16.77M | 11.39M |
|
|||||
Total Current Assets | 11.14M | 13.51M | 15.00M | 16.77M | 11.39M |
Net Property, Plant & Equipment | 362.90K | 418.10K | 424.00K | 480.40K | 507.50K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 623.90K | 646.40K | 668.80K | 691.30K | 713.70K |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 148.70K | -- | 22.40K | 9.50K | -- |
Total Assets | 12.28M | 14.57M | 16.12M | 17.95M | 12.61M |
|
|||||
Total Accounts Payable | 483.10K | 401.40K | 215.90K | 230.90K | 189.40K |
Total Accrued Expenses | 744.50K | 682.20K | 447.60K | 338.30K | 711.70K |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | 42.40K | 83.60K | 123.50K | 162.30K |
Total Finance Division Other Current Liabilities | 2.52M | 3.46M | 4.57M | 2.76M | 1.54M |
Total Other Current Liabilities | 2.52M | 3.46M | 4.57M | 2.76M | 1.54M |
Total Current Liabilities | 3.75M | 4.58M | 5.32M | 3.45M | 2.61M |
|
|||||
Total Current Liabilities | 3.75M | 4.58M | 5.32M | 3.45M | 2.61M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 3.75M | 4.58M | 5.32M | 3.45M | 2.61M |
|
|||||
Common Stock & APIC | 164.20M | 164.02M | 163.74M | 163.41M | 156.69M |
Retained Earnings | -155.68M | -154.04M | -152.95M | -148.92M | -146.70M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 8.52M | 9.98M | 10.79M | 14.49M | 9.99M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 14.00K | 14.00K | 14.00K | 14.00K | 14.00K |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 14.00K | 14.00K | 14.00K | 14.00K | 14.00K |
|
|||||
Total Common Equity | 8.52M | 9.98M | 10.79M | 14.49M | 9.99M |
Total Preferred Equity | 14.00K | 14.00K | 14.00K | 14.00K | 14.00K |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 8.53M | 9.99M | 10.80M | 14.50M | 10.00M |
|